Armstrong, A. W., Paul, C., Puig Sanz, L., Boehncke, W., Freeman, M., Torii, H., . . . Lebwohl, M. G. (2019). Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis.
Citación estilo ChicagoArmstrong, April W., et al. Safety of Ixekizumab Treatment for Up to 5 Years in Adult Patients With Moderate-to-Severe Psoriasis. 2019.
Cita MLAArmstrong, April W., et al. Safety of Ixekizumab Treatment for Up to 5 Years in Adult Patients With Moderate-to-Severe Psoriasis. 2019.
Precaución: Estas citas no son 100% exactas.